Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026
    Facebook X (Twitter) Instagram
    • Home
    • Contact Us
    Addis Ababa WeeklyAddis Ababa Weekly
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Addis Ababa WeeklyAddis Ababa Weekly
    Home » Revolutionary sepsis diagnostic AI by Prenosis receives FDA nod
    Health

    Revolutionary sepsis diagnostic AI by Prenosis receives FDA nod

    April 4, 2024
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email

    The U.S. Food and Drug Administration (FDA) has granted approval to Prenosis’ groundbreaking artificial intelligence-powered diagnostic tool for sepsis, marking a significant milestone in the realm of healthcare technology. Sepsis, a life-threatening condition triggered by the body’s extreme response to infection, has long posed diagnostic challenges to medical professionals. With over 350,000 adult fatalities annually in the United States alone, according to the Centers for Disease Control and Prevention, timely diagnosis is crucial due to the rapid deterioration sepsis patients can experience.

    Revolutionary sepsis diagnostic AI by Prenosis receives FDA nod

    Prenosis’ innovative solution, named Sepsis ImmunoScore, leverages 22 distinct parameters such as temperature, heart rate, and cell counts to provide clinicians with a comprehensive assessment of sepsis risk. Unlike traditional methods that require individual monitoring of these parameters, Sepsis ImmunoScore utilizes AI to simultaneously evaluate all indicators, generating an overall risk score and four risk categories indicative of patient deterioration likelihood.

    The development of Sepsis ImmunoScore was underpinned by Prenosis’ Immunix platform, which drew upon a vast dataset comprising over 100,000 blood samples from 25,000 diverse patients. Integrated seamlessly into electronic health records, the tool facilitates easy accessibility and utilization by healthcare professionals. Notably, clinicians utilizing Sepsis ImmunoScore will have visibility into the specific parameters contributing to the risk score, enhancing transparency and clinical decision-making.

    Securing FDA approval via the De Novo pathway marks a significant achievement for the Chicago-based startup, affirming the novelty and efficacy of its AI diagnostic tool. While Prenosis leads the charge in FDA-approved sepsis diagnostic AI, other entities have also ventured into similar terrain. Johns Hopkins University, for instance, has developed an AI system aimed at early sepsis detection, exhibiting promising outcomes in detecting sepsis symptoms ahead of traditional methods.

    Meanwhile, Epic Systems, a prominent healthcare software vendor, has faced scrutiny over its AI-powered sepsis prediction tool. Despite widespread adoption, studies have raised questions about its performance, prompting the company to revamp its model. In contrast, Prenosis prioritized collaboration with regulatory bodies to ensure the safety and effectiveness of Sepsis ImmunoScore, illustrating its commitment to responsible innovation.

    The FDA’s updated guidance underscores the importance of regulatory oversight in the development of medical software, particularly for life-threatening conditions like sepsis. Prenosis’ rigorous 18-month endeavor to demonstrate the tool’s safety and efficacy reflects a dedication to upholding regulatory standards. With FDA approval secured, Prenosis is poised to embark on further studies to validate Sepsis ImmunoScore’s accuracy and influence on clinical decision-making, heralding a new era in sepsis management.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email

    Related Posts

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026

    Dengue kills 173 in October as Bangladesh toll climbs to 418

    November 2, 2026

    Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

    November 2, 2026

    Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

    October 28, 2026
    Latest News

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Prabowo says DEFA can unlock $2 trillion ASEAN digital economy

    November 18, 2026

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026

    Damascus becomes Air Arabia Dammam’s second foreign route

    November 17, 2026

    Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

    November 17, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026
    © 2026 Addis Ababa Weekly | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.